We studied the effects of the anesthetics commonly used in cardiac surgery
on platelet function. Fentanyl, droperidol, succinylcholine, pancuronium, t
hiopental, and diazepam at therapeutic concentrations were tested for their
in vitro effects on the expression of platelet membrane glycoproteins Ib a
nd IIbIIIa (GpIb, GpIIb-IIIa) and of P-selectin in anticoagulated whole blo
od by flow cytometry. The expression of P-selectin was determined under bas
al conditions, after the incubation of blood with adenosine diphosphate (AD
P) 10 mu mol/L, and the stable prostaglandin endoperoxide analog U46619 1 m
u mol/L. No drug affected the expression of P-selectin in unstimulated and
ADP- or US6619-stimulated platelets, with the exception of thiopental, whic
h markedly decreased the U46619-induced expression of P-selectin. Thiopenta
l concentration-dependently inhibited U46619-induced and ADP-induced platel
et aggregation, with effects on U46619-induced aggregation at therapeutic c
oncentrations. To assess au vivo effects, the same platelet markers were al
so assessed in blood obtained from 10 patients undergoing elective coronary
surgery, Compared with basal values, platelet response to U46619 was signi
ficantly reduced just after the administration of anesthetic drugs, and the
effect persisted for 48 h after surgery. Our study suggests that, at thera
peutic concentrations, thiopental inhibits U46619-induced platelet activati
on bo th in vitro and ex vivo. The mechanisms responsible of this effect, t
ogether with its clinical significance, require further investigation Impli
cations: Thiopental inhibited prostaglandin-induced platelet activation at
therapeutic concentrations both in vitro and ex vivo in cardiac surgical pa
tients whereas adenosine diphosphate-induced activation was affected only a
t supratherapeutic drug concentrations. Thus, administration of sodium thio
pental may contribute to the in vivo impairment of platelet function in pat
ients undergoing elective cardiac surgery.